レオクラン rose for the third straight session after revising its consolidated earnings forecast for the fiscal year ending September 2026 upward after the close on the 14th. The stock was also bought up to ¥1,064 at one point today.
レオクラン, which provides package sales of medical equipment, has risen for the third consecutive session. The stock was seen as benefiting from the company’s upward revision to its consolidated earnings forecast for the fiscal year ending September 2026 after the close on the 14th.
During trading hours the same day, the stock rose to ¥1,064 at one point.